26.06.2024
Your partner for innovative medicines in emerging markets
In the recent months, we have strategically expanded our portfolio with several novel products, marking a significant step forward in...
Acino
News
24.06.2024
Acino signs an exclusive licensing and supply agreement with Allecra Therapeutics in Gulf Cooperation Council countries and South Africa
The agreement focuses on the distribution of Allecra’s novel antibiotic drug EXBLIFEP® (cefepime/enmetazobactam) within the Republic of South Africa and...
17.06.2024
Acino in Ukraine Achieves GDP Certification
For the first time, Acino in Ukraine has received the Certificate of Good Distribution Practice (GDP). Following a rigorous inspection...
13.06.2024
A family introduction: The Urso Russos love the work environment at Acino
Father Giuseppe and his sons Michele and Filippo joined Acino’s bulk production site as production operators in Liesberg in 2022...
15.05.2024
From Junior to Leader: Patrick Frey’s rapid ascent at Acino
Patrick Frey rose within just six years from a junior position in Out-Licensing to Head of B2B at Acino. Here...
07.05.2024
Acino signs an exclusive license agreement with Supernus in Latin America
M8 Pharmaceuticals, an Acino company (‘M8’) announces that the company has signed an exclusive licensing agreement with Supernus Pharmaceuticals, Inc....
29.04.2024
Acino tops the list of best employers in the Ukrainian pharmaceutical sector
Acino has been recognised as the top employer among pharmaceutical companies in Ukraine. This ranking is the result of a...
02.04.2024
Acino announces new regional leadership and hub to deliver on expanded presence and capabilities in Latin America following M8 acquisition
Joel Barlan has been appointed as Head of the LATAM region. Mexico City will now serve as a regional hub...
25.03.2024
Acino appoints Samir El Nasharty as Chief Operations Officer
We are pleased to announce the appointment of Samir El Nasharty as Chief Operations Officer and member of Acino’s Executive...